Introduction
The development of metastatic disease is a major driver of mortality in patients [1] . During tumour progression, oxygen tension in the microenvironment surrounding the tumour cells is reduced, resulting in intratumoral hypoxia [2, 3] . Cancer cells are able to resist the negative effects of hypoxia predominantly via stabilizing and thus promoting the activity of transcription factor hypoxia-inducible factor-1 (HIF-1) [4] . It is well established that HIF-1a can promote angiogenesis [5] ; however, tumour hypoxia is also linked to increased metastatic potential in several types of cancers [6] [7] [8] .
While promotion of angiogenesis has been extensively studied, the molecular mechanisms coupling hypoxia to metastasis are less well understood. In recent years, evidence has started to emerge that HIF-1a activity might also influence the intrinsic invasive behaviour of the cancer cell. HIF-1a activity has been implicated in the induction of epithelial to mesenchymal transition [9] , and downregulation of HIF-1a expression has been reported to suppress glioma, colon cancer and melanoma cell migration in vitro [10] [11] [12] . Expression analysis has revealed that a number of genes which regulate cancer invasion, such as CXCR4, pyruvate dehydrogenase kinase 1 matrix metalloproteinase 2, urokinase plasminogen activator receptor and fibronectin 1 are regulated by HIF-1a [11, 12] .
Indeed, it has recently been shown that HIF-1a can modulate cell migration via induction of JMY expression [13] , and that HIF-1a may regulate c-Met and RhoE expression levels [14, 15] .
To escape the confines of the primary tumour, cancer cells invade the surrounding stroma and migrate towards local vasculature. Such tissue invasion requires cells to degrade extracellular matrix. Cancer cells are thought to employ actinrich membrane protrusions, termed invadopodia, to achieve matrix degradation [16, 17] . Invadopodia provide protrusive force coupled with the delivery of matrix-degrading metalloproteases to drive cell invasion, and are characterized in vitro as having an actin-rich central core associated with cortactin [17] . Invadopodia are similar in architecture and function to the well-characterized invasive protrusions used by haematopoietic cells, termed podosomes [17] . In recent years, invadopodia have been identified in cancer cells from many different tissue types, including breast, and have been studied extensively in vitro [18] . Moreover, there is now emerging evidence that these processes are also employed in vivo [19] . Many proteins have been implicated in regulating the formation of invadopodia, including members of the Rho family GTPases Rac and Cdc42 [20] , p-21-activated kinases [21] , and proteins also associated with other forms of cellsubstratum adhesion such as paxillin and N-WASP [22, 23] . It has been shown that invadopodia activity can be increased by exposure to growth factor signalling, and it has been suggested that exposing cancer cells to a hypoxic environment can lead to increased invasive activity [24] , although this study did not link invadopodia formation to the level of HIF-1a expression. Moreover, how invadopodia-forming activity is induced by extracellular signals and coordinated within the cell remains to be fully understood. To better understand specifically how increased levels of HIF-1a contribute to invasive behaviour, we have investigated the formation of invadopodia in breast cancer cells under hypoxic conditions using chemical induction, environmental and overexpression approaches.
Results and discussion

HIF-1a expression increases invadopodia formation
An established protocol to mimic hypoxia-induced stabilization of HIF-1a in cancer cells is to use di-methyl-oxaloylglycine (DMOG), a cell-permeable pan-hydroxylase inhibitor [25] . Addition of DMOG to the cell culture medium quickly stabilized HIF-1a levels (figure 1a) with no change in HIF-2a expression levels (figure 1a). Moreover, we found a significant increase in the number of cells exhibiting invadopodia-forming activity in the presence of DMOG (figure 1b,c). Furthermore, this result was replicated in a second cancer cell line: A375 melanoma cells (see the electronic supplementary material, figure S1c-e). While we were surprised to detect changes in invadopodia formation following 6 h in the presence of DMOG, this is not altogether unexpected as others have shown changes in protein levels following 3 h addition of DMOG [26] . Interestingly, we found that sustained presence of DMOG throughout the assay further elevated the response (figure 1b,c). Not only did a higher percentage of the cell population exhibit invadopodia-forming activity, but we also noted that there appeared to be an increase in gelatin degradation in those cells that had been exposed to DMOG. These observations were confirmed by quantifying the level of degradation per cell (figure 1d; electronic supplementary material, figure S1f). Thus, DMOG not only increases levels of invadopodia activity, but also stimulates increased degradative activity in those cells.
These results suggested that HIF-1a directly influences the behaviour of the cancer cells. DMOG is a pan-hydroxylase inhibitor that can not only inhibit the HIF prolyl hydroxylases, but also other hydroxylases [25] ; and DMOG has been associated with non-HIF-1a-associated events [27] . To validate the role of HIF-1a in driving an increase in invadopodia-forming activity, we specifically reduced the level of HIF-1a expression in DMOG-maintained cells without affecting the level of related protein HIF-2a (figure 1e; electronic supplementary material, figure S1b). In the background of reduced HIF-1a expression, we found that DMOG was no longer able to stimulate an increased level of invadopodia formation in these cells ( figure 1f) . Interestingly, degradation analysis of those cells in the HIF-1a population that were able to initiate some invadopodia-forming activity in the presence of DMOG revealed a significant reduction in degradative ability. The significant decrease in gelatin degradation further emphasizes the specific importance of HIF-1a expression in the generation of efficient invasive capacity.
Our findings support a specific role for HIF-1a in invadopodia formation. We next tested whether overexpression of HIF-1a alone could increase invadopodia-forming potential. We generated a green fluorescent protein (GFP)-tagged HIF-1a construct which was able to overcome endogenous HIF-1a degradation pathways and deliver a significant increase in HIF-1a expression, without altering levels of HIF-2a (see the electronic supplementary material, figure S1c; figure 2a) as well as correctly localizing to the nucleus (see the electronic supplementary material, figure S2a). GFP-HIF-1a functioned normally in cells, as demonstrated by the increase in VEGF expression detected in cells expressing GFP-HIF-1a (see the electronic supplementary material, figure S2b). Satisfied that GFP-HIF-1a is functionally active, we measured the invadopodia-forming ability of GFP-HIF-1a-expressing cells. GFP-HIF-1a-expressing cells exhibited a significant increase in invadopodia formation compared with control cells and increased levels of gelatin degradation (figure 2b).
To complement our induced HIF-1a studies, we used a hypoxia incubator. Incubation of cells under hypoxic conditions stabilized HIF-1a levels, with no effect on HIF-2a levels (figure 2c). However, HIF-1a is rapidly degraded when cells are removed from the hypoxia incubator (data not shown). Thus, we were unable to remove cells from the incubator and seed onto gelatin coverslips without losing HIF-1a expression. Instead, by seeding the cells onto gelatin coverslips first and then keeping the cells under hypoxic conditions, we were able to show that increased HIF-1a expression (figure 2c) resulted in a concomitant increase in matrix degradation (figure 2d) when compared with cells seeded onto gelatin coverslips and maintained in normoxic conditions. Taken together these results strongly support a role for hypoxia, via HIF-1a activity, in driving invasive potential.
HIF-1a regulates expression of cytoskeletalassociated proteins
We reasoned that the effect of HIF-1a expression may result from changes in invadopodia-specific cytoskeletal-related rsob.royalsocietypublishing.org Open Biol 3: 120159 gene expression. To test this hypothesis, we performed PCR array analysis of gene expression following addition of DMOG. As expected, VEGFA and c-Met levels were significantly increased upon the addition of DMOG, but we also found increased expression of a number of cytoskeletal-related genes, including Cdc42, Arp2 and b-PIX (figure 3a; electronic supplementary material, table S1). This is the first time that Arp2 and b-PIX have been identified as potentially HIF-1a regulated. Cdc42 and Arp2 are known regulators of invadopodia formation [23] , and we validated HIF-1a-induced Arp2 levels (see the electronic supplementary material, figure S2c,d). In contrast, while b-PIX has been associated with increased formation of actin columns in podosome-forming smooth muscle cells, it has not been directly linked to invadopodia formation or matrix degradation.
b-PIX is a guanine nucleotide exchange factor for Rac and Cdc42 that has been implicated in the regulation of cell adhesion and cell migration [28, 29] . b-PIX is found in a complex with PAK, a protein thought to regulate invadopodia formation [21] , thus we decided to investigate the link between b-PIX, HIF-1a and invadopodia formation.
A role for b-PIX in invadopodia formation
We have been able to confirm at the RNA (figure 3b,c) and protein level (figure 4a,b) that increased HIF-1a levels lead to increased levels of b-PIX using both DMOG and expression of GFP-HIF-1a. Moreover, we have identified a putative HIF1a response element in the b-PIX gene (see the electronic supplementary material, figure S2e). In addition, we detect 
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an increase in b-PIX expression when cells are switched to a hypoxic environment (figure 4c). We next speculated that invadopodia formation induced by HIF-1a might be mediated at least in part through the activity of b-PIX. Strikingly, we found that a reduction in b-PIX expression (figure 4d) leads to a dramatic decrease in invadopodia formation even under basal conditions (figure 4e), and that this reduction in activity could also be detected in a second cancer cell line (see the electronic supplementary material, figure S3 ). This would suggest a fundamental requirement for b-PIX activity. This role for b-PIX would seem to be distinct from a previously identified role in adhesion disassembly [28] , and suggests that the activity of b-PIX is both spatially and temporally regulated. This fundamental requirement for b-PIX activity is further emphasized by the finding that, in a background of b-PIX knockdown, neither DMOG treatment nor GFP-HIF-1a overexpression is able to induce invadopodia formation in cells to control levels ( figure 4e,f) . There is still an induction in invadopodia formation in the b-PIX knockdown background; however, this activity could also be attributed to the fact that b-PIX levels recover in the presence of DMOG (see right lane in figure 4d ). These data suggest that HIF-1a elevates b-PIX expression, because b-PIX is a fundamental driver of invadopodia formation, rather than that b-PIX only functions in a HIF-1a transcriptional pathway. Indeed, it is probably that HIF-1a may act through multiple cytoskeletal pathways to induce invadopodia formation, a hypothesis supported by our array studies. Nevertheless, our studies point to an essential requirement for b-PIX activity. Given these novel findings, we then tested whether overexpression of b-PIX might also influence invadopodia-forming activity in these cells. We found a striking increase in the level of invadopodia formation in cells expressing GFP-b-PIX compared with GFP alone (figure 5a). This was further reflected in the level of gelatin degradation detected in b-PIX-overexpressing cells (figure 5b). Indeed, cells expressing GFP-b-PIX exhibited the highest level of gelatin degradation recorded in this study, again suggesting that HIF-1a upregulates b-PIX expression as a means to directly increase invasive potential. A role for b-PIX in invadopodia formation has not been previously reported, but PIX family members have been implicated in the regulation of podosome formation [30, 31] , and b-PIX was putatively localized to actin puncta at the cell periphery of those smooth muscle cells. We also found that GFP-b-PIX was localized to the cell periphery, but could also be detected in a cloud around the central core of the cell, often concentrated over the area of predominant gelatin degradation (see the electronic supplementary material, figure S3c; figure 5c). Moreover, in some cells it was possible to localize GFP-b-PIX puncta to areas of gelatin degradation, and this was more obvious in cells that had been treated with DMOG ( figure 5c arrow and figure 5d arrowhead) .
b-PIX is normally associated with focal adhesion dynamics via its interaction with PAK and GIT1, most recently linked to the disassembly of such adhesions [32] . GIT1 is an ADP-ribosylation factor GTPase-activating protein (ARFGAP), which specifically regulates ARF6 [33] . Interestingly, ARF6 has been implicated in the formation of invadopodia downstream of hepatocyte growth factor (HGF) [34] , and ARF6 was transcriptionally upregulated by stabilization of HIF-1a in our array (figure 3a). Given this close relationship, it might be reasonable to speculate that the requirement for b-PIX in invadopodia formation could also implicate GIT1, ARF6 and/or PAK family proteins. However, our data suggest that in the context of invadopodia dynamics b-PIX is a driver of assembly rather than a driver of disassembly. It will be interesting to discover whether the same b-PIX-associated protein interactions function in both scenarios. To further validate our hypothesis that b-PIX is a potent driver of invadopodia formation, we expressed GFP-b-PIX in DMOG-treated cells in the presence of HIF-1a-specific siRNA oligos. Consistent with our previous results, reduced HIF-1a expression prevented cells from responding to DMOG treatment. However, in cells where HIF-1a levels were reduced but b-PIX levels were elevated by overexpression of GFP-b-PIX, we found a level of invadopodia-forming activity comparable with control cells (figure 5e). Taken together, these data clearly establish an important, direct and novel link between HIF-1a, invadopodia formation and the Rho family activator b-PIX. 
Reagents
Anti-HIF-1a, anti-p44/42 MAPK (Erk1/2) anti-Cool1/b-PIX were purchased from Cell Signaling Technology (Danvers, MA). Anti-Arp2 was purchased from Abcam (Cambridge, MA). Anti-EPAS1/HIF-2a and anti-GAPDH were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-b-actin was purchased from Sigma. HRP-conjugated anti-mouse and anti-rabbit were purchased from Dako. Gelatin was from porcine skin type A, Rhodamine B isothiocyanate. Human fulllength HIF-1a cDNA clone was purchased from Origene Technologies. GFP-HIF-1a (pDEST201 plasmid) expression vector was generated using Gateway-Cloning System (Invitrogen).
Mouse GFP-b-PIX was a kind gift from Dr. Jeff Peterson, Fox Chase Cancer Centre, Philadelphia, USA.
Preparation of gelatin-coated coverslips
Briefly, gelatin was dissolved in 61 mM NaCl, 50 mM NaB4 ph9.3 at 378C for 1 h, Rhodamine (Sigma) added to the gelatin rsob.royalsocietypublishing.org Open Biol 3: 120159
buffer and mixed for 4 h in the dark at room temperature. The rhodamine-conjugated gelatin (TRITC-gelatin) was then dialysed against PBS. Dialysed TRITC-gelatin was stored with sucrose. Sterile acid-washed coverslips were coated with pre-warmed TRITC-gelatin solution incubated in 0.5 per cent glutaraldehyde in the dark and then washed with sterile PBS. The coverslips were quenched with 5 mg ml -1 sodium borohydride-PBS at room temperature in the dark followed rsob.royalsocietypublishing.org Open Biol 3: 120159
by washing with sterile PBS. The coverslips were then sterilized in 70 per cent ethanol, dried and quenched with DMEM for 1 h at 378C.
RNAi
MDA-MB-231 cells were seeded at a density of 4 Â 10 4 cell ml 21 in 2 ml complete growth medium, allowed to adhere for 24 h and transfected with siRNA oligos using HiPerfect (Qiagen) according to the manufacturer's protocol. Cells were transfected with 75 nM small interfering (si) RNA targeting HIF-1a (Ambion, catalogue no. 4392420) or 75 nM non-specific siRNA (Qiagen) as control. For b-PIX siRNA, 75 nM of a pool of four siRNA duplexes each designed to target human b-PIX (siGENOME SMARTpool) was transfected for 24 h.
PCR analysis
Total cellular RNA was isolated with an RNeasy Plus Mini Kit (Qiagen). Template cDNAs were synthesized with Superscript III (Invitrogen). Semi-quantitative reverse-transcriptase (RT)-PCR was performed with Red-Taq PCR mix (Sigma). See the electronic supplementary material for primer sequences used. A Human Cell Motility PCR Array was purchased from SABiosciences (a Qiagen company). cDNA template was mixed with the ready-to-use PCR master mix and loaded onto an ABI 7700 HT sequence detector (Applied Biosystems, Foster City, CA). Data were analysed using a web-based analysis tool (SABiosciences).
Immunoblotting and immunofluorescence
Cells were lysed and immunoblotted as previously described [35] . The cells were fixed with 4 per cent paraformaldehyde and permeabilized in 0.2 per cent triton X-100/PBS followed by PBS washes. Cells were then incubated with Alexa Fluor 488 phalloidin for 1 h. Cells were then washed twice with PBS. Cells were imaged on an Olympus IX71 fluorescence microscope and a LSM 510 Zeiss confocal microscope. For percentage of cells with invadopodia quantification, individual cells were imaged at high magnification (maximum three cells per field of view) and scored for the presence of punctate gelatin degradation under the cell area as determined by F-actin staining.
Gelatin degradation analysis
IMAGEJ software (gelatin degradation plug-in by kind gift of Prof. Laura Machesky) was used to measure area of matrix degradation per invadopodia-forming cell. Cell and gelatin images were converted to 8 bits copy prior to combining all cell and gelatin images in separate stack (cell images in one stack and gelatin images on another stack). These stacks were then opened in IMAGEJ software to measure total degradation area per cell. Data were then multiplied by pixel area (square micrometres) to get real degradation area.
